Clinical Trial Update: Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating a combination of epirubicin, docetaxel, and pegfilgrastim in women with locally advanced or inflammatory breast cancer has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Epirubicin (epirubicin)
• NEULASTA (pegfilgrastim)
• Taxotere (docetaxel)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED